A carregar...

Phase II Study of Afatinib as Third-Line Treatment for Patients in Korea With Stage IIIB/IV Non-Small Cell Lung Cancer Harboring Wild-Type EGFR

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Ahn, Myung-Ju, Kim, Sang-We, Cho, Byoung-Chul, Ahn, Jin Seok, Lee, Dae Ho, Sun, Jong-Mu, Massey, Dan, Kim, Miyoung, Shi, Yang, Park, Keunchil
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4425374/
https://ncbi.nlm.nih.gov/pubmed/25956899
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2013-0419erratum
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!